vs

Side-by-side financial comparison of SYNCHRONOSS TECHNOLOGIES INC (SNCR) and X4 Pharmaceuticals, Inc (XFOR). Click either name above to swap in a different company.

SYNCHRONOSS TECHNOLOGIES INC is the larger business by last-quarter revenue ($42.0M vs $28.8M, roughly 1.5× X4 Pharmaceuticals, Inc). SYNCHRONOSS TECHNOLOGIES INC runs the higher net margin — 13.8% vs 1.0%, a 12.9% gap on every dollar of revenue.

Synchronoss Technologies Inc develops cloud-based digital transformation, subscriber management and messaging solutions for global telecom operators and enterprise clients. Its core offerings support connectivity onboarding, IoT service enablement, with key markets spanning North America, Europe and Asia-Pacific.

X4 Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel targeted therapies for rare immunological diseases and oncology indications with high unmet medical needs. It operates primarily across the U.S. and European markets, with a lead pipeline candidate for WHIM syndrome and multiple other preclinical and clinical assets for immune disorders and cancer.

SNCR vs XFOR — Head-to-Head

Bigger by revenue
SNCR
SNCR
1.5× larger
SNCR
$42.0M
$28.8M
XFOR
Higher net margin
SNCR
SNCR
12.9% more per $
SNCR
13.8%
1.0%
XFOR

Income Statement — Q3 FY2025 vs Q1 FY2025

Metric
SNCR
SNCR
XFOR
XFOR
Revenue
$42.0M
$28.8M
Net Profit
$5.8M
$282.0K
Gross Margin
79.4%
83.6%
Operating Margin
14.0%
-32.8%
Net Margin
13.8%
1.0%
Revenue YoY
-2.2%
Net Profit YoY
201.7%
100.5%
EPS (diluted)
$0.51
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SNCR
SNCR
XFOR
XFOR
Q3 25
$42.0M
Q2 25
$42.5M
Q1 25
$42.2M
$28.8M
Q4 24
$44.2M
Q3 24
$43.0M
Q2 24
$43.5M
Q1 24
$43.0M
$0
Q4 23
$41.4M
Net Profit
SNCR
SNCR
XFOR
XFOR
Q3 25
$5.8M
Q2 25
$-19.6M
Q1 25
$-3.8M
$282.0K
Q4 24
$7.9M
Q3 24
$-5.7M
Q2 24
$-494.0K
Q1 24
$4.5M
$-51.8M
Q4 23
$-32.4M
Gross Margin
SNCR
SNCR
XFOR
XFOR
Q3 25
79.4%
Q2 25
79.0%
Q1 25
79.4%
83.6%
Q4 24
78.6%
Q3 24
79.1%
Q2 24
76.1%
Q1 24
76.2%
Q4 23
75.1%
Operating Margin
SNCR
SNCR
XFOR
XFOR
Q3 25
14.0%
Q2 25
16.1%
Q1 25
19.5%
-32.8%
Q4 24
16.5%
Q3 24
12.8%
Q2 24
9.9%
Q1 24
10.7%
Q4 23
0.4%
Net Margin
SNCR
SNCR
XFOR
XFOR
Q3 25
13.8%
Q2 25
-46.1%
Q1 25
-9.0%
1.0%
Q4 24
17.8%
Q3 24
-13.3%
Q2 24
-1.1%
Q1 24
10.4%
Q4 23
-78.4%
EPS (diluted)
SNCR
SNCR
XFOR
XFOR
Q3 25
$0.51
Q2 25
$-1.87
Q1 25
$-0.37
$0.04
Q4 24
$0.75
Q3 24
$-0.56
Q2 24
$0.01
Q1 24
$0.23
$-7.77
Q4 23
$-3.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SNCR
SNCR
XFOR
XFOR
Cash + ST InvestmentsLiquidity on hand
$34.8M
$40.3M
Total DebtLower is stronger
$163.2M
$75.0M
Stockholders' EquityBook value
$55.4M
$22.9M
Total Assets
$278.2M
$130.0M
Debt / EquityLower = less leverage
2.95×
3.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SNCR
SNCR
XFOR
XFOR
Q3 25
$34.8M
Q2 25
$24.6M
Q1 25
$29.1M
$40.3M
Q4 24
$33.4M
Q3 24
$25.2M
Q2 24
$23.6M
Q1 24
$19.1M
$60.5M
Q4 23
$24.6M
Total Debt
SNCR
SNCR
XFOR
XFOR
Q3 25
$163.2M
Q2 25
$186.2M
Q1 25
$187.0M
$75.0M
Q4 24
$186.7M
Q3 24
$186.4M
Q2 24
$186.2M
Q1 24
$136.6M
$55.0M
Q4 23
$136.2M
Stockholders' Equity
SNCR
SNCR
XFOR
XFOR
Q3 25
$55.4M
Q2 25
$49.4M
Q1 25
$35.4M
$22.9M
Q4 24
$29.8M
Q3 24
$35.3M
Q2 24
$30.6M
Q1 24
$24.0M
$1.0M
Q4 23
$26.6M
Total Assets
SNCR
SNCR
XFOR
XFOR
Q3 25
$278.2M
Q2 25
$291.4M
Q1 25
$293.3M
$130.0M
Q4 24
$293.8M
Q3 24
$299.7M
Q2 24
$295.7M
Q1 24
$298.5M
$112.2M
Q4 23
$310.3M
Debt / Equity
SNCR
SNCR
XFOR
XFOR
Q3 25
2.95×
Q2 25
3.77×
Q1 25
5.28×
3.27×
Q4 24
6.27×
Q3 24
5.28×
Q2 24
6.08×
Q1 24
5.70×
53.09×
Q4 23
5.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SNCR
SNCR
XFOR
XFOR
Operating Cash FlowLast quarter
$39.4M
$-12.4M
Free Cash FlowOCF − Capex
$39.0M
FCF MarginFCF / Revenue
92.9%
Capex IntensityCapex / Revenue
0.9%
0.0%
Cash ConversionOCF / Net Profit
6.77×
-43.86×
TTM Free Cash FlowTrailing 4 quarters
$53.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SNCR
SNCR
XFOR
XFOR
Q3 25
$39.4M
Q2 25
$2.3M
Q1 25
$293.0K
$-12.4M
Q4 24
$13.1M
Q3 24
$3.4M
Q2 24
$11.3M
Q1 24
$527.0K
$-33.6M
Q4 23
$-407.0K
Free Cash Flow
SNCR
SNCR
XFOR
XFOR
Q3 25
$39.0M
Q2 25
$2.0M
Q1 25
$-31.0K
Q4 24
$12.2M
Q3 24
$3.2M
Q2 24
$10.9M
Q1 24
$10.0K
$-33.7M
Q4 23
$-480.0K
FCF Margin
SNCR
SNCR
XFOR
XFOR
Q3 25
92.9%
Q2 25
4.6%
Q1 25
-0.1%
Q4 24
27.6%
Q3 24
7.5%
Q2 24
25.2%
Q1 24
0.0%
Q4 23
-1.2%
Capex Intensity
SNCR
SNCR
XFOR
XFOR
Q3 25
0.9%
Q2 25
0.8%
Q1 25
0.8%
0.0%
Q4 24
1.9%
Q3 24
0.3%
Q2 24
0.9%
Q1 24
1.2%
Q4 23
0.2%
Cash Conversion
SNCR
SNCR
XFOR
XFOR
Q3 25
6.77×
Q2 25
Q1 25
-43.86×
Q4 24
1.66×
Q3 24
Q2 24
Q1 24
0.12×
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SNCR
SNCR

Subscription Services$39.4M94%
Professional Services$2.6M6%

XFOR
XFOR

Segment breakdown not available.

Related Comparisons